Epizyme, Inc. Gains 21.73%

Fri, May 07, 2021 at 05:33 PM
Epizyme, Inc. Gains 21.73%

Epizyme, Inc. (EPZM:NASDAQ) soared at $8.29, representing a gain of 21.7%. On Thu, May 06, 2021, EPZM:NASDAQ hit a New 2-Week Low of $6.81. The stock appeared on our News Catalysts scanner on Fri, May 07, 2021 at 11:01 AM in the 'UPGRADE' category. From Thu, Apr 22, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days

The share price of the company has been moving sideways in recent weeks.

About Epizyme, Inc. (EPZM:NASDAQ)

Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.